DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE
0836.671.322 · rovalta.com · 26/09/2026
DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBODR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE is a Private limited company incorporated in 2011. Its main activity is: General medical practice activities. Its registered office is in Bruxelles.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0836.671.322
- Incorporation
- 31/05/2011
- Legal form
- Private limited company
- Registered office
- Pl. du Nouveau Marché aux Grains 13
1000 Bruxelles · BruxellesSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2024
Financials
Source · NBB, 15 filingsTrend over 14 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 355,6 k € | -3.7% | 369,3 k € | +20.8% | 305,7 k € | -11.4% | 344,9 k € | +21.7% | 283,3 k € |
| EBITDA | 274,1 k € | -8.8% | 300,4 k € | +22.4% | 245,5 k € | -15.1% | 289,1 k € | +22.9% | 235,3 k € |
| Operating result | 180 k € | +3.5% | 173,8 k € | -1.4% | 176,2 k € | -22.8% | 228,1 k € | +20.6% | 189,2 k € |
| Net result | 119,7 k € | +2.2% | 117,1 k € | -1.4% | 118,7 k € | -24.9% | 158,1 k € | +26.9% | 124,6 k € |
| Balance sheet | |||||||||
| Equity | 659,8 k € | +2.9% | 641 k € | +0.3% | 638,9 k € | +4.2% | 613,2 k € | +20.6% | 508,6 k € |
| Total assets | 1,1 M € | -5.7% | 1,2 M € | +1.1% | 1,2 M € | +4.1% | 1,1 M € | +16.8% | 980,3 k € |
| Cash | 331,4 k € | +80.7% | 183,5 k € | -62.1% | 484,2 k € | +43.1% | 338,4 k € | +43.8% | 235,3 k € |
| Debts | 476,2 k € | -15.6% | 564 k € | +2.0% | 552,7 k € | +3.9% | 531,9 k € | +12.8% | 471,7 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20241 active · 3 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/10/2025 | 04/11/2024 | 18/09/2023 | 03/10/2022 | 25/10/2021 | 03/12/2020 |
| General meeting | 31/10/2025 | 31/10/2024 | 08/09/2023 | 01/09/2022 | 07/06/2021 | 01/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 31/10/2025 | 31/10/2025 | Dutch | |
| Micro model | 31/12/2023 | 31/10/2024 | 04/11/2024 | Dutch | |
| Micro model | 31/12/2022 | 08/09/2023 | 18/09/2023 | Dutch | |
| Micro model | 31/12/2021 | 01/09/2022 | 03/10/2022 | Dutch | |
| Micro model | 31/12/2020 | 07/06/2021 | 25/10/2021 | Dutch | |
| Micro model | 31/12/2019 | 01/06/2020 | 03/12/2020 | Dutch | |
| Micro modelCorrection | 31/12/2018 | 03/06/2019 | 13/11/2020 | Dutch | |
| Micro model | 31/12/2018 | 03/06/2019 | 09/10/2019 | Dutch | |
| Micro model | 31/12/2017 | 04/06/2018 | 28/09/2018 | Dutch | |
| Abridged model | 31/12/2016 | 05/06/2017 | 29/09/2017 | Dutch | |
| Abridged model | 31/12/2015 | 20/12/2016 | 09/01/2017 | Dutch | |
| Abridged model | 31/12/2014 | 01/06/2015 | 31/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 02/06/2014 | 27/09/2014 | Dutch | |
| Abridged model | 31/12/2012 | 03/06/2013 | 14/11/2013 | Dutch | |
| Abridged model | 31/12/2011 | 04/06/2012 | 08/11/2012 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 3 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024119,7 k €↑
- 2023Annual accounts 2023117,1 k €↓
- 2022Annual accounts 2022118,7 k €↓
- 2021Annual accounts 2021158,1 k €↑
- 2020Annual accounts 2020124,6 k €↑
- 2019Annual accounts 201998,8 k €↓
- 2018Annual accounts 2018122,9 k €↑
- 2017Annual accounts 201793,1 k €↑
- 2016Annual accounts 201653,5 k €↑
- 2015Annual accounts 201542,7 k €↓
- 2014Annual accounts 201465,8 k €↑
- 2013Annual accounts 201333,9 k €↑
- 2012Annual accounts 201231,2 k €↑
- 2011Annual accounts 201125,8 k €
- 31/05/2011IncorporationPrivate limited company